Anniek M C Gielen, Niels M Leijten, Payal P S Balraadjsing, Hedwig M Braakhuis, Hannah Abee, Jacobus J Arts, Annemarie P van Wezel, Agnes G Oomen, Nick R M Beijer
{"title":"Utilizing biomaterial surface properties to improve orthopedic hip implant safety and function in a Safe-by-Design approach.","authors":"Anniek M C Gielen, Niels M Leijten, Payal P S Balraadjsing, Hedwig M Braakhuis, Hannah Abee, Jacobus J Arts, Annemarie P van Wezel, Agnes G Oomen, Nick R M Beijer","doi":"10.3389/fbioe.2025.1504883","DOIUrl":null,"url":null,"abstract":"<p><p>Orthopedic hip implant failure due to adverse events, such as infection, are still a major problem leading to high morbidity and mortality. Over the years, various innovative biomaterials have been investigated to improve safety and functionality of implants. Although novel biomaterials show initial promising results, many fail at the (later) stages of safety testing. We performed a literature review serving as a first step in a Safe-by-Design (SbD) approach. SbD is a strategy which includes safety considerations at early development stages and that streamlines the pre-clinical safety assessment of innovative medical implants. In a SbD approach, the standard safety assessment of medical implants (e.g., ISO10993) is complemented with insights on cell-biomaterial interactions allowing for a better <i>in vivo</i> response prediction. As a first step, these insights are based on existing information from literature. Therefore, in this review, correlations between implant biomaterial surface properties and key biological processes, relevant for the success and safety of titanium hip implants, are investigated. In particular, the influence of biomaterial roughness, wettability and pore size on key biological processes for a hip implant (osseointegration, bacterial adhesion and the immune response) are examined. Although it was found that no ideal combination of properties exist to satisfy the key biological processes simultaneously, the gathered insights provide directions for the development of safe and functional biomaterials. Altogether, an assessment of the different aspects of safety at early development stages within an SbD approach can improve biomaterial functionality and thus safety.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1504883"},"PeriodicalIF":4.3000,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11885263/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1504883","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Orthopedic hip implant failure due to adverse events, such as infection, are still a major problem leading to high morbidity and mortality. Over the years, various innovative biomaterials have been investigated to improve safety and functionality of implants. Although novel biomaterials show initial promising results, many fail at the (later) stages of safety testing. We performed a literature review serving as a first step in a Safe-by-Design (SbD) approach. SbD is a strategy which includes safety considerations at early development stages and that streamlines the pre-clinical safety assessment of innovative medical implants. In a SbD approach, the standard safety assessment of medical implants (e.g., ISO10993) is complemented with insights on cell-biomaterial interactions allowing for a better in vivo response prediction. As a first step, these insights are based on existing information from literature. Therefore, in this review, correlations between implant biomaterial surface properties and key biological processes, relevant for the success and safety of titanium hip implants, are investigated. In particular, the influence of biomaterial roughness, wettability and pore size on key biological processes for a hip implant (osseointegration, bacterial adhesion and the immune response) are examined. Although it was found that no ideal combination of properties exist to satisfy the key biological processes simultaneously, the gathered insights provide directions for the development of safe and functional biomaterials. Altogether, an assessment of the different aspects of safety at early development stages within an SbD approach can improve biomaterial functionality and thus safety.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.